Resource library: Reagent resource for studying SARS-CoV-2 variants

Posted: 23 February 2021 | | No comments yet

Sino Biological has developed 80+ mutant proteins covering the newest mutations identified in SARS-CoV-2 variants, such as UK’s B.1.1.7, Brazil’s P.1.

Sino Biological has developed 80+ recombinant RBD/Spike and Nucleocapsid protein mutants carrying the mutations of high interest, such as N501Y and E484K identified in three new fast-spreading SARS-CoV-2 variants, UK’s B.1.1.7, Brazil’s P.1, and South Africa’s B.1.351, emerging in recent months, to support evaluating the efficacy of the antibodies and vaccination.

    To read this resource library in full, please complete the form below:


    This specialist content is provided to you free-of-charge thanks to the kind support of Sino Biological

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.